ZOMBA, 12 October 2018 – The Malawi High Court yesterday granted an urgent interim injunction preventing the return of six persons diagnosed with multidrug-resistant TB (MDR-TB) to prison.

Having pro-health intellectual property (IP) laws ensures access to essential medicines.

AIDS & Rights Alliance for Southern Africa (ARASA) are offering an online training course for civil society organizations in Africa. The training will help HIV and health activist groups challenge intellectual property barriers that impede access to affordable medicines.

The AIDS and Rights Alliance for Southern Africa (ARASA) and UNDP Regional Service Centre for Africa, under the Africa Regional Grant on HIV: Removing Legal Barriers, will host the second Africa Regional Dialogue on HIV, TB and the Law on 3-4 August 2017 in Johannesburg, South Africa.

Call for applications to participate in the ARASA 2017 annual Training of Trainers Program on HIV, TB and human rights in Southern and East Africa

Applications are invited for participation in the AIDS & Rights Alliance for Southern Africa (ARASA) and International Treatment Preparedness Coalition (ITPC) 2016 online training course on “Addressing Intellectual Property Barriers in African countries: Improving Access to sustainable availability & access to affordable, quality, safe & efficacious essential medicines”.

As the Regional Community Partner for the 2016 International AIDS Conference (AIDS 2016), ARASA is committed to assisting civil society and community members to be able to attend the conference, to host activities or workshops and to facilitate presentations about their work.

The guide serves as a framework for activists in Southern and East Africa working on HIV, TB and human rights issues in the region. It aims to provide a starting point for activists to identify the key advocacy priorities relating to TB and human rights in their own countries.

The report details the role that gold mining has in driving the TB epidemic in southern Africa, and calls for a step up in political and corporate will for developing a coordinated international response to the disease.